MedPath

The effectiveness of a Mediterranean diet on hormonal, metabolic and body composition in overweight and obese women with Polycystic Ovary Syndrome.

Not Applicable
Recruiting
Conditions
Polycystic Ovary Syndrome
Metabolic and Endocrine - Other endocrine disorders
Registration Number
ACTRN12621000994886
Lead Sponsor
Dr Anthony Villani
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
42
Inclusion Criteria

1. Confirmed diagnosis of Polycystic Ovary Syndrome according to the Rotterdam criteria which is based on participants presenting with two of the three following criteria including: 1) menstrual irregularity (infrequent menstrual periods) and/or anovulation; 2) clinical and/or biochemical hyperandrogenism; 3) polycystic ovaries based on ultrasound examination.

2. Body mass index of 25kg/m2 or more

Exclusion Criteria

Participants will be excluded based on the following criteria:
Pregnancy
Type 2 diabetes
Current use of hormonal contraceptives or insulin sensitizing drugs
High adherence to a MedDiet defined as a score >10 using the 14-item Mediterranean diet adherence screener (MEDAS)
Cushing's syndrome
Hypothyroidism
Androgen tumors
Active cancer

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath